5 most read GI stories: Nov. 28 to Dec. 2, 2016

Here were the five most read gastroenterology/endoscopy stories on Becker’s ASC Review for the week of Nov. 28 to Dec. 2, 2016.

Advertisement

1. CMS proposed 2017 physician fee schedule eliminates moderate sedation from endoscopic procedures: 6 things to know
Click here

2. Endoscopy combined with antiplatelets or anticoagulant agents safe for identifying GI bleeding: 5 key notes
Click here

3. Boston Scientific hedges bets on endoscopic division, analysts project $5B valuation: 6 things to know
Click here

4. Metastatic tumor-destroying vaccine for colon cancer patients to begin phase II trial: 6 key notes
Click here

5. GI View hoping disposable colonoscope system can change the game
Click here

More articles on gastroenterology/endoscopy:
AGA Patient INFO Center integrates with gMed: 3 notes
Allergan’s GI business grows by 8.2% in Q3 & more — 3 GI company key notes
Valeant, Takeda deal crumbles; Valeant to invest in Salix: 6 things to know 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.